8-KThe WireRoutine
Shareholder Vote · Company Update
Filed Aug 23, 2024 · 1y ago · Accession 0001213900-24-072251
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Aug 23, 2024
- Report date
- Aug 22, 2024
- Document
- ea021219701-8k_arcabio.htm
- Size
- 271 KB